Maureen Su

A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center, including MIMG Faculty member Dr. Maureen Su, revealed possible therapeutic targets and mechanisms for people who experience immune-related adverse events (IRAEs). By understanding how autoimmune toxicities develop in patients treated with cancer immunotherapy, researchers can develop strategies to reduce these side effects, thus making treatment safer.

To read more about this study, visit the UCLA Health article